Bevacizumab (B) in the adjuvant treatment of breast cancer - first toxicity results from Eastern Cooperative Oncology Group trial E5103. - Miller, K. D.; O'Neill, A.; Dang, C.; Northfelt, D.; Gradishar, W.; Sledge, G. W. (Cancer Research, 2012)